Apimeds Pharmaceuticals US (APUS) Interest Coverage Ratio (2024 - 2025)
Apimeds Pharmaceuticals US's (APUS) quarterly Interest Coverage Ratio came in at 25.29 in Q4 2025, down 893.43% YoY from 3.19 in Q4 2024, and up 91.36% on a QoQ basis from 292.69 in Q3 2025.
Apimeds Pharmaceuticals US (APUS) Interest Coverage Ratio (2024 - 2025) Analysis & Trends
Apimeds Pharmaceuticals US (APUS) has 2 years of Interest Coverage Ratio data on file, last reported at 25.29 in Q4 2025.
- Quarterly Interest Coverage Ratio fell 893.43% year-over-year to 25.29 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 34.45 (down 413.19% YoY) and the FY2025 annual result came in at 4.5, down 302.94% from the prior year.
- Interest Coverage Ratio improved to 25.29 in Q4 2025, from 292.69 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 2.55 in Q4 2024 to a low of 292.69 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Apimeds Pharmaceuticals US | 7.20 Mn | 7.20 Mn | - | -1.95 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -25.29 |
| Sep 30, 2025 | -292.69 |
| Jun 30, 2025 | -115.55 |
| Mar 31, 2025 | -9.58 |
| Dec 31, 2024 | -2.55 |
| Sep 30, 2024 | -9.19 |
| Jun 30, 2024 | -19.34 |
| Mar 31, 2024 | -10.10 |